piRNA: Epigenetic Regulators of Genome Stability, Development and Disease

piRNA-Mediated Epigenetic Regulation
Transgenerational Epigenetic Regulation
Interactions With Small Non-coding RNA
piRNA in Development and Disease
Conclusion
References and Further Reading

Piwi-interacting RNA (piRNA) is a small non-coding RNA (sncRNA) of 24-32 nucleotides.¹ Unlike protein-coding RNAs, piRNAs regulate gene activity by binding to PIWI proteins, a subfamily of Argonaute proteins, forming the PIWI–piRNA complex.

Image Credit: Joyisjoyful/Shutterstock.com

These molecules play a central role in maintaining genome stability, particularly in germ cells, where they silence transposons and guide epigenetic regulation. Through mechanisms such as DNA methylation, histone modification, and transgenerational inheritance, piRNAs contribute to long-term gene silencing and genome protection. Their functions also intersect with other small non-coding RNA pathways and are increasingly being linked to human disease.

During gametogenesis, this complex plays a key role in silencing transposons and protecting the genome through epigenetic regulation.² The epigenetic machinery maintains the genome while altering chromatin structure, thereby repressing transcription and inducing long-term gene silencing.³

Save this PDF for later by downloading it here.

piRNA-Mediated Epigenetic Regulation

A key way in which piRNAs maintain genome stability is through epigenetic regulation of gene expression, particularly the silencing of transposons. This regulation is carried out by the PIWI–piRNA complex through coordinated molecular mechanisms.

piRNAs are generated from long precursor transcripts derived from piRNA clusters, which are trimmed and cleaved into mature piRNAs. The piRNA binds to a PIWI protein, forming the PIWI protein complex.⁴ The PIWI protein silences genes by recruiting an enzyme. This occurs through two different mechanisms: DNA methylation and histone modification.  

The first of these mechanisms, DNA methylation, occurs when the PIWI–piRNA complex binds to complementary transposon sequences and recruits a methyltransferase. This enzyme adds a methyl group to cytosine residues, forming 5-methylcytosine, which represses transcription and effectively silences the targeted gene.⁵

During histone modification, the histone methyltransferase, recruited by the PIWI protein, deposits the repressive mark histone 3 lysine 9 (H3K9me3). The repressive marker condenses chromatin, forming heterochromatin.⁶ The condensed structure prevents the enzyme RNA polymerase from accessing the DNA, so transcription cannot occur.^{4, 6} 

In germ cells, gene silencing is maintained and reinforced post-transcriptionally through the ping-pong amplification cycle. The cycle increases piRNA levels and enables long-term gene silencing. In somatic cells, ping-pong amplification is typically absent.⁴

The silencing and maintenance of genes is essential in preventing transposon activation and insertion, which can lead to mutations. The piRNAs’ role in guiding gene silencing maintains and protects the integrity of the germline genome. 

Transgenerational Epigenetic Regulation

While piRNA-mediated mechanisms silence transposons within individual cells, their effects can also extend beyond a single generation. In germ cells, epigenetic regulation is not only maintained during development but can also be inherited, allowing gene silencing to persist across generations.

Most of the human genome is non-coding RNA, including transposons once thought to be ‘junk’.⁷ However, these serve an evolutionary purpose in generating genetic diversity. Transposons are DNA sequences that can move to different parts of the genome, damaging DNA and causing mutations that would be passed through the germline.⁸ 

Through transgenerational inheritance, epigenetic changes that do not alter the genome are maintained across cell divisions. During germline development, the genome is methylated, but methylated cytosines are not removed because they are protected by epigenetic memory marks, such as proteins and chromatin modifications, which prevent demethylation.⁹

This was first evidenced in Drosophila, where the mother's DNA is the major source of transgenerational genome defense.^9,10 In this model, the methylated cytosine is a transgenerational epigenetic inheritance mark, which maintains gene silencing across 50 generations in Drosophila.¹¹

In germ cells, piRNAs are derived from double-stranded clusters, providing greater base diversity for targeting a variety of transposons.⁹ The regulation of piRNAs is important for species evolution, as silencing transposons across generations prevents mutations and maintains the genome. As this research is largely limited to Drosophila and mice, findings may not directly apply to humans. 

Interactions With Small Non-coding RNA

piRNAs belong to a group of sncRNAs that includes microRNAs (miRNAs) and small interfering RNAs (siRNAs). These sncRNAs are short RNA molecules that share similar pathways and guide Argonaute family proteins to regulate gene expression by binding to specific nucleic acids.^3,12 However, these sncRNAs have distinct mechanisms and functions. 

piRNAs are distinct in that they associate exclusively with PIWI proteins and silence transposons at both transcriptional and post-transcriptional levels, with a specific role in maintaining germline genome stability.¹² In contrast, miRNAs associate with AGO1-4 proteins to silence genes post-transcriptionally, while siRNAs utilize the same AGO proteins for transcriptional silencing, primarily as a defense against viruses and transposons.^12,3

In Drosophila, these sncRNA pathways are distinct but overlap, as miRNA and siRNA direct mRNA transcripts that serve as precursors of piRNA production.¹³ However, again, there is no evidence of this in human germ cells.

piRNA in Development and Disease

The piRNA pathway is essential for germ cell development and fertility, as it protects germline cells from transposons that can disrupt proper gene expression. Disruption of piRNA biogenesis can render a germ cell sterile.¹⁴ Beyond the germ cells, silencing transposons is critical for maintaining cell identity throughout cell division. 

Recent research in mammals has shown that piRNA is essential for spermatogenesis and may contribute to post-testicular sperm maturation. Emerging evidence suggests piRNAs may also have intergenerational effects, influencing early embryonic development.¹⁵

In tumors, PIWI proteins and piRNAs have complex and sometimes opposing roles, acting as either promoters or suppressors of tumorigenesis depending on the genes they regulate.¹⁶ Both PIWI proteins and piRNAs are highly expressed in germ cells and in various tumor tissues, whereas most somatic cells exhibit little to no piRNA expression. This contrast has made piRNAs an area of particular interest in cancer research.

Interestingly, some studies suggest that PIWI proteins and piRNAs may function independently in tumor contexts, although this remains under investigation.⁴ Due to their role in disease, piRNAs may serve as biomarkers for Parkinson’s disease and a variety of cancers, and may influence tumor cell drug resistance, potentially enhancing chemotherapy sensitivity.^17,18

Conclusion

piRNAs are essential for regulating genome stability, epigenetic inheritance, and gene expression, and there is increasing evidence to suggest that piRNA biomarkers have huge potential when it comes to diagnosing and treating human diseases, including cancer and neurodegenerative conditions. 

However, research on somatic cells is limited by low piRNA levels, making it difficult to establish the mechanisms underlying piRNA in disease. In addition, most piRNA research has been conducted in Drosophila and mice, limiting the extent to which these mechanisms can be applied to human disease.

Further research in somatic and human systems is needed to clarify the mechanisms of piRNAs in disease and to strengthen their potential for clinical application. As understanding of these pathways improves, piRNAs may become increasingly important in both molecular biology and the development of targeted therapeutic strategies. 

References and Further Reading

1. Salem, D.P., Bortolin, L.T., Gusenleitner, D., Grosha, J., Zabroski, I.O., Biette, K.M., Banerjee, S., Sedlak, C.R., Byrne, D.M., Hamzeh, B.F. and King, M.S. (2024). Colocalization of cancer-associated biomarkers on single extracellular vesicles for early detection of cancer. The Journal of Molecular Diagnostics, 26(12), pp.1109-1128. DOI:10.1016/j.jmoldx.2024.08.006, https://doi.org/10.1016/j.jmoldx.2024.08.006
2. Sadoughi, F., Mirhashemi, S.M. and Asemi, Z. (2021). Epigenetic roles of PIWI proteins and piRNAs in colorectal cancer. Cancer Cell International, 21(1), DOI:10.1186/s12935-021-02034-3, https://doi.org/10.1186/s12935-021-02034-3
3. Sato, K. and Siomi, M.C. (2020). The piRNA pathway in Drosophila ovarian germ and somatic cells. Proceedings of the Japan Academy, Series B, 96(1), pp.32-42. DOI:10.2183/pjab.96.003, https://doi.org/10.2183/pjab.96.003
4. Zhang, Q., Zhu, Y., Cao, X., Tan, W., Yu, J., Lu, Y., Kang, R., Wang, X. and Li, E. (2023). The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers. Molecular Cancer, 22(1), DOI:10.1186/s12943-023-01749-3, https://doi.org/10.1186/s12943-023-01749-3
5. Loubalova, Z., Konstantinidou, P. and Haase, A.D. (2023). Themes and variations on piRNA-guided transposon control. Mobile DNA, 14(1), DOI:10.1186/s13100-023-00298-2, https://doi.org/10.1186/s13100-023-00298-2
6. Jia, D.D., Jiang, H., Zhang, Y.F., Zhang, Y., Qian, L.L. and Zhang, Y.F. (2022). The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation. International journal of biological sciences, 18(8), pp. 3358–3373. DOI:10.7150/ijbs.68221, https://doi.org/10.7150/ijbs.68221
7. Bure, I.V., Nemtsova, M.V. and Kuznetsova, E.B. (2022). Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis. International Journal of Molecular Sciences, 23(10), DOI:10.3390/ijms23105801, https://doi.org/10.3390/ijms23105801
8. Sadoughi, F., Mirhashemi, S.M. and Asemi, Z. (2021). Epigenetic roles of PIWI proteins and piRNAs in colorectal cancer. Cancer Cell International, 21(1), DOI:10.1186/s12935-021-02034-3, https://doi.org/10.1186/s12935-021-02034-3
9. Tracy, L. and Zhang, Z. (2025). Transposon persistence and control in germ cells. Current Opinion in Genetics & Development, 93, DOI:10.1016/j.gde.2025.102370, https://doi.org/10.1016/j.gde.2025.102370
10. Moelling, K. (2024). Epigenetics and transgenerational inheritance. The Journal of Physiology, 602(11), pp.2537-2545. DOI:10.1113/JP284424, https://doi.org/10.1113/JP284424
11. Malone, C.D., Brennecke, J., Dus, M., Stark, A., McCombie, W.R., Sachidanandam, R. and Hannon, G.J. (2009). Specialized piRNA pathways act in germline and somatic tissues of the Drosophila ovary. Cell, 137(3), pp.522-535 DOI:10.1016/j.cell.2009.03.040, https://doi.org/10.1016/j.cell.2009.03.040.
12. Casier, K., Boivin, A., Carré, C. and Teysset, L. (2019). Environmentally-induced transgenerational epigenetic inheritance: implication of PIWI interacting RNAs. Cells, 8(9), DOI:10.3390/cells8091108, https://doi.org/10.3390/cells8091108
13. 12Chen, S., Ben, S., Xin, J., Li, S., Zheng, R., Wang, H., Fan, L., Du, M., Zhang, Z. and Wang, M. (2021). The biogenesis and biological function of PIWI-interacting RNA in cancer. Journal of hematology & oncology, 14(1), p.93. DOI:10.1186/s13045-021-01104-3, https://doi.org/10.1186/s13045-021-01104-3
14. Iki, T., Kawaguchi, S. and Kai, T. (2023). miRNA/siRNA-directed pathway to produce noncoding piRNAs from endogenous protein-coding regions ensures Drosophila spermatogenesis. Science Advances, 9(29), DOI:10.1126/sciadv.adh0397, https://doi.org/10.1126/sciadv.adh0397
15. Stallmeyer, B., Bühlmann, C., Stakaitis, R., Dicke, A.K., Ghieh, F., Meier, L., Zoch, A., MacKenzie MacLeod, D., Steingröver, J., Okutman, Ö. and Fietz, D. (2024). Inherited defects of piRNA biogenesis cause transposon de-repression, impaired spermatogenesis, and human male infertility. Nature communications, 15(6637), DOI:10.1038/s41467-024-50930-9, https://doi.org/10.1038/s41467-024-50930-9
16. Perillo, G., Shibata, K. and Wu, P.H. (2023). piRNAs in sperm function and embryo viability. Reproduction, 165(3), DOI:10.1530/REP-22-0312, https://doi.org/10.1530/REP-22-0312
17. Han, Y.N., Li, Y., Xia, S.Q., Zhang, Y.Y., Zheng, J.H. and Li, W. (2018). PIWI proteins and PIWI-interacting RNA: emerging roles in cancer. Cellular Physiology and Biochemistry, 44(1), pp.1-20. DOI:10.1159/000484541, https://doi.org/10.1159/000484541
18. Wu, Z., Yu, X., Zhang, S., He, Y. and Guo, W. (2023). Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases. Cell Communication and Signaling, 21(343), DOI:10.1186/s12964-023-01368-x, https://doi.org/10.1186/s12964-023-01368-x
19. Zhang, T. and Wong, G. (2022). Dysregulation of human somatic piRNA expression in Parkinson’s disease subtypes and stages. International journal of molecular sciences, 23(5), DOI:10.3390/ijms23052469, https://doi.org/10.3390/ijms23052469

Last Updated: Mar 27, 2026